Glycéokinase d'Escherichia coli, poudre lyophilisée, 50-100 unités/mg de protéines

Code: g4509-1ku D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Glycerol kinase (glpK) was used to study the effects of pain controlling neuropeptides on human fat cell lipolysis.

Biochem/physiol Actions...


en savoir plus

Votre prix
$680.05 EACH

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Glycerol kinase (glpK) was used to study the effects of pain controlling neuropeptides on human fat cell lipolysis.

Biochem/physiol Actions

Glycerol kinase catalyzes tge MgATP-dependent phosphorylation of glycerol to produce sn-glycerol-3-phosphate and is the rate limiting enzyme in the utilization of glycerol. ﹤﹤﹤20,21>>> It is also subject to feedback regulation by fructose-1,6-bisphosphate.﹤﹤﹤22>>>

Glycerol kinase catalyzes tge MgATP-dependent phosphorylation of glycerol to produce sn-glycerol-3-phosphate and is the rate limiting enzyme in the utilization of glycerol. It is also subject to feedback regulation by fructose-1,6-bisphosphate.

Packaging

1000 units in serum bottle

Physical form

Partially purified lyophilized powder, balance is primarily salts and EDTA.

Unit Definition

One unit will convert 1.0 µmole of glycerol and ATP to L-α-glycerophosphate and ADP per min at pH 9.8 at 25 °C in a coupled system with PK/LDH.

biological sourceEscherichia coli
compositionProtein, ≥50% biuret
foreign activityTriose-phosphate isomerase, hexokinase, myokinase, glycerol dehydrogenase and NADH oxidase ≤0.05%
formlyophilized powder
Quality Level200
specific activity40-100 units/mg protein
storage temp.−20°C
Cas Number9030-66-4
Ce produit répond aux critères suivants: